Insulet Omnipod 5, Руководство по уходу

Страница: 3 / 13

SECTION 1 | BASICS SECTION 1 | BASICS
This guide will help you feel comfortable taking care of someone with
diabetes using the Omnipod
® 5 Automated Insulin Delivery System.
Let’s start with the basics!
What is type 1 diabetes?
Type 1 diabetes is a chronic disease where the pancreas produces little
to no insulin. People with diabetes need to replace the insulin their
pancreas cannot make, either through injections or an insulin pump
(standard or automated).
How do insulin pumps work?
Insulin pumps deliver insulin in two different ways, with basal and bolus doses.
Basal insulin covers background insulin needed to keep glucose levels in
range between meals and overnight.
Bolus insulin is an additional dose of insulin needed for food (meal bolus)
and/or to lower high glucose levels (correction bolus).
Insulin delivery in standard insulin pump therapy
Insulin delivery in Automated Insulin Delivery (AID) Systems
In AID systems like Omnipod ® 5, automated insulin delivery is adjusted
automatically based on continuous glucose monitor (CGM) values. With
Omnipod 5, the system automatically increases, decreases or pauses
insulin delivery every 5 minutes based on where glucose is predicted
to be 60 minutes into the future.
How Omnipod 5 works
Insulin Delivered From Pod
0
50
100
150
200
250
300
TIME 7 AM 1 PM
mg/dL
HELPS PROTECT AGAINST LOWS
1,2
When your levels are dropping, SmartAdjust™
technology automatically decreases or
pauses insulin delivery.
HELPS PROTECT AGAINST HIGHS
1,2
When your levels are rising, SmartAdjust™
technology automatically increases
insulin delivery.
CUSTOMIZABLE TARGET GLUCOSE LEVEL
GLUCOSE VALUES
GLUCOSE
LEVELS
INSULIN
DELIVERY
HOW IT WORKS
1. Study in 240 people with T1D aged 6 -70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target
Glucose range (from CGM) for standard therapy vs Omnipod 5 in adults/adolescents = 64.7% vs. 73.9% and children = 52.5% vs. 68.0%. Brown et al. Diabetes Care (2021).
2. Study in 80 people with T1D aged 2 –5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target
Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. SherrJL, et al. Diabetes Care (2022).
Document #: INS-OHS-09-2021-00002 V2.0
Bolus Insulin
Basal Insulin
1. Study in 240 people with T1D aged 6 -70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average
time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 in adults/adolescents = 64.7% vs. 73.9% and children = 52.5% vs. 68.0%. Brown
et al. Diabetes Care (2021).
2. Study in 80 people with T1D aged 2 –5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average
time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. SherrJL, et al. Diabetes Care (2022).
NOTE!
The Omnipod 5 System
will always pause insulin
delivery when glucose
is below 60 mg/dL.
4 5